2023
DOI: 10.1016/s1470-2045(23)00102-x
|View full text |Cite
|
Sign up to set email alerts
|

First-in-patient study of OTL78 for intraoperative fluorescence imaging of prostate-specific membrane antigen-positive prostate cancer: a single-arm, phase 2a, feasibility trial

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
18
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 19 publications
(18 citation statements)
references
References 27 publications
0
18
0
Order By: Relevance
“…The exact resolution of IS-002 is yet to be determined. The sensitivity of ex vivo imaging with OLT78 was higher than its in vivo imaging, because the limited range of motion of a laparoscope and limited range of fluorescence may cause difficulties in the in vivo visualization of the apex of the prostate, which is located in the deep region of pelvis 15 . Compared with the laparoscope, robotic surgery systems may greatly facilitate deep pelvic visualization and can be better integrated into a robot-assisted fluorescence-guided surgery workflow.…”
Section: Psma-fgsmentioning
confidence: 99%
See 4 more Smart Citations
“…The exact resolution of IS-002 is yet to be determined. The sensitivity of ex vivo imaging with OLT78 was higher than its in vivo imaging, because the limited range of motion of a laparoscope and limited range of fluorescence may cause difficulties in the in vivo visualization of the apex of the prostate, which is located in the deep region of pelvis 15 . Compared with the laparoscope, robotic surgery systems may greatly facilitate deep pelvic visualization and can be better integrated into a robot-assisted fluorescence-guided surgery workflow.…”
Section: Psma-fgsmentioning
confidence: 99%
“…In a single-arm, phase 2a, feasibility trial, Stibbe et al showed that OTL78 was well tolerated and had the potential to achieve complete oncological resection of PSMs and positive LNMs, with the optimal dose of 30 µg/kg at 24 h preoperatively (Figures 4 - 5 ) 15 . Similarly, Nguyen et al conducted a phase 1, single-center, dose-escalation study to evaluate another near-infrared agent, IS-002, in 24 men with high-risk PCa by RP+ePLND 16 .…”
Section: Psma-fgsmentioning
confidence: 99%
See 3 more Smart Citations